Novartis has recently announced that they are taking significant measures to support the global crisis, due to the COVID-19 pandemic, by creating a global fund of twenty-million dollars to support communities around the world.
Novartis has established an accelerated global review process which will allow for quick approval and disbursement of individual grants up to one-million dollars.
“Novartis has recently announced that they are taking significant measures to support the global crisis“
Novartis’s CEO, Vas Narasimhan, stated: "We are dealing with an extraordinary and unprecedented public health crisis that requires an incredible level of involvement and collaboration across government, society and business. As a medicines company present in over one-hundred and forty countries, we are stepping in to provide additional financial support to critical community or national programs that can help address urgent public health needs resulting from the COVID-19 pandemic. Recognizing the power of working together as an industry we are also bringing the talent and capabilities of our industry leading R&D organization to two leading and important collaborative R&D initiatives."